pp 1–17 | Cite as

Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys

  • Veronica GoEmail author
  • Bethany G. E. Bowley
  • Monica A. Pessina
  • Zheng Gang Zhang
  • Michael Chopp
  • Seth P. Finklestein
  • Douglas L. Rosene
  • Maria Medalla
  • Benjamin Buller
  • Tara L. Moore
Original Article


Cortical injury, such as injuries after stroke or age-related ischemic events, triggers a cascade of degeneration accompanied by inflammatory responses that mediate neurological deficits. Therapeutics that modulate such neuroinflammatory responses in the aging brain have the potential to reduce neurological dysfunction and promote recovery. Extracellular vesicles (EVs) from mesenchymal stem cells (MSCs) are lipid-bound, nanoscale vesicles that can modulate inflammation and enhance recovery in rodent stroke models. We recently assessed the efficacy of intravenous infusions of MSC-EVs (24-h and 14-days post-injury) as a treatment in aged rhesus monkeys (Macaca mulatta) with cortical injury that induced impairment of fine motor function of the hand. Aged monkeys treated with EVs after injury recovered motor function more rapidly and more fully than aged monkeys given a vehicle control. Here, we describe EV-mediated inflammatory changes using histological assays to quantify differences in markers of neuroinflammation in brain tissue between EV and vehicle-treated aged monkeys. The activation status of microglia, the innate macrophages of the brain, is critical to cell fate after injury. Our findings demonstrate that EV treatment after injury is associated with greater densities of ramified, homeostatic microglia, along with reduced pro-inflammatory microglial markers. These findings are consistent with a phenotypic switch of inflammatory hypertrophic microglia towards anti-inflammatory, homeostatic functions, which was correlated with enhanced functional recovery. Overall, our data suggest that EVs reduce neuroinflammation and shift microglia towards restorative functions. These findings demonstrate the therapeutic potential of MSC-derived EVs for reducing neuroinflammation after cortical injury in the aged brain.


Extracellular vesicles Cortical injury Rhesus Monkeys 



Extracellular vesicles


Mesenchymal stem cells


Perilesional gray matter


Sublesional white matter



We would like to acknowledge our staff, Penny Schultz and Karen Slater, and graduate students, Karen Bottenfield, Katelyn Trecartin, Samantha Calderazzo, and Ajay Uprety, for their invaluable assistance with this study.


This work was supported by the NIH grants R21-NS102991, R21NS111174, and U01-NS076474 and the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant Number 1UL1TR001430.

Compliance with ethical standards

Competing interests

The authors declare that they have no competing interests.


  1. Anderson JD et al (2016) Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling. Stem Cells 34:601–613CrossRefGoogle Scholar
  2. Baker M (2009) Why hES cells make teratomas. Nature Reports Stem Cells Available at: [Accessed March 12, 2019]
  3. Bang OY, Lee JS, Lee PH, Lee G (2005) Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874–882CrossRefGoogle Scholar
  4. Casado JG, Blázquez R, Vela FJ, Álvarez V, Tarazona R, Sánchez-Margallo FM (2017) Mesenchymal stem cell-derived exosomes: immunomodulatory evaluation in an antigen-induced synovitis porcine model. Front Vet Sci 4 Available at: [Accessed March 12, 2019]
  5. Chavez JC, Hurko O, Barone FC, Feuerstein GZ (2009) Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke 40 Available at: [Accessed January 3, 2019]
  6. Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M (2001) Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189:49–57CrossRefGoogle Scholar
  7. Chiu KB, Lee KM, Robillard KN, MacLean AG (2019) A method to investigate astrocyte and microglial morphological changes in the aging brain of the Rhesus Macaque. Methods Mol Biol 1938:265–276CrossRefGoogle Scholar
  8. Chopp M, Li Y (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol 1:92–100CrossRefGoogle Scholar
  9. Chopp M, Zhang ZG (2015) Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/diseases. Expert Opin Emerg Drugs 20:523–526CrossRefGoogle Scholar
  10. Chopp M, Li Y, Zhang ZG (2009) Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke 40:S143–S145CrossRefGoogle Scholar
  11. Cui X, Chopp M, Shehadah A, Zacharek A, Kuzmin-Nichols N, Sanberg CD, Dai J, Zhang C, Ueno Y, Roberts C, Chen J (2012) Therapeutic benefit of treatment of stroke with simvastatin and human umbilical cord blood cells: neurogenesis, synaptic plasticity, and axon growth. Cell Transplant 21:845–856CrossRefGoogle Scholar
  12. Dubbelaar ML, Kracht L, Eggen BJL, Boddeke EWGM (2018) The kaleidoscope of microglial phenotypes. Front Immunol 9 Available at: [Accessed March 12, 2019]
  13. Estrada A et al (2017) Impending extinction crisis of the world’s primates: why primates matter. Science Advances 3:e1600946CrossRefGoogle Scholar
  14. Fiala JC, Harris KM (2001) Extending unbiased stereology of brain ultrastructure to three-dimensional volumes. J Am Med Inform Assoc 8:1–16CrossRefGoogle Scholar
  15. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan W-B, Julius D (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9:1512–1519Google Scholar
  16. Jarmalavičiūtė A, Pivoriūnas A (2016) Exosomes as a potential novel therapeutic tools against neurodegenerative diseases. Pharmacol Res 113:816–822CrossRefGoogle Scholar
  17. Jeong CH, Kim SM, Lim JY, Ryu CH, Jun JA, Jeun S-S (2014) Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model. BioMed Research International Available at: [Accessed January 3, 2019]
  18. Justicia C, Ramos-Cabrer P, Hoehn M (2008) MRI detection of secondary damage after stroke. Stroke 39:1541–1547CrossRefGoogle Scholar
  19. Karperien A, Ahammer H, Jelinek HF (2013) Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci 7 Available at: [Accessed January 3, 2019]
  20. Kaushal V, Schlichter LC (2008) Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci 28:2221–2230CrossRefGoogle Scholar
  21. Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, Zahoor H, Saeed D, Natteru PA, Iyer S, Zaheer A (2017) Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci 11 Available at: [Accessed January 3, 2019]
  22. Kohman RA, Rhodes JS (2013) Neurogenesis, inflammation and behavior. Brain, Behavior, and Immunity 27:22–32CrossRefGoogle Scholar
  23. Liu Z, Li Y, Zhang ZG, Cui X, Cui Y, Lu M, Savant-Bhonsale S, Chopp M (2010) Bone marrow stromal cells enhance inter- and intracortical axonal connections after ischemic stroke in adult rats. J Cereb Blood Flow Metab 30:1288–1295CrossRefGoogle Scholar
  24. McColl SR, Mahalingam S, Staykova M, Tylaska LA, Fisher KE, Strick CA, Gladue RP, Neote KS, Willenborg DO (2004) Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands. Laboratory Investigation 84:1418–1429CrossRefGoogle Scholar
  25. Medalla M, Luebke JI (2015) Diversity of glutamatergic synaptic strength in lateral prefrontal versus primary visual cortices in the rhesus monkey. J Neurosci 35:112–127CrossRefGoogle Scholar
  26. Moore TL, Bowley BGE, Pessina MA, Calderazzo SM, Medalla M, Go V, Zhang ZG, Chopp M, Finklestein S, Harbaugh AG, Rosene DL, Buller B (2019) Mesenchymal derived exosomes enhance recovery of motor function in a monkey model of cortical injury. Restorative Neurology and Neuroscience 37:347–362CrossRefGoogle Scholar
  27. Orczykowski ME, Calderazzo SM, Shobin E, Pessina MA, Oblak AL, Finklestein SP, Kramer BC, Mortazavi F, Rosene DL, Moore TL (2019) Cell based therapy reduces secondary damage and increases extent of microglial activation following cortical injury. Brain Research 1717:147–159CrossRefGoogle Scholar
  28. Orihuela R, McPherson CA, Harry GJ (2016) Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173:649–665CrossRefGoogle Scholar
  29. Patel AR, Ritzel R, McCullough LD, Liu F (2013) Microglia and ischemic stroke: a double-edged sword. International journal of physiology, pathophysiology and pharmacology 5:73–90PubMedPubMedCentralGoogle Scholar
  30. Phinney DG, Pittenger MF (2017) Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells 35:851–858CrossRefGoogle Scholar
  31. Rodriguez A, Ehlenberger DB, Hof PR, Wearne SL (2006) Rayburst sampling, an algorithm for automated three-dimensional shape analysis from laser scanning microscopy images. Nat Protoc 1:2152–2161CrossRefGoogle Scholar
  32. Rosene DL, Roy NJ, Davis BJ (1986) A cryoprotection method that facilitates cutting frozen sections of whole monkey brains for histological and histochemical processing without freezing artifact. J Histochem Cytochem 34:1301–1315CrossRefGoogle Scholar
  33. Schnell SA, Staines WA, Wessendorf MW (1999) Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 47:719–730CrossRefGoogle Scholar
  34. Shobin E, Bowley MP, Estrada LI, Heyworth NC, Orczykowski ME, Eldridge SA, Calderazzo SM, Mortazavi F, Moore TL, Rosene DL (2017) Microglia activation and phagocytosis: relationship with aging and cognitive impairment in the rhesus monkey. GeroScience 39:199–220CrossRefGoogle Scholar
  35. Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53:1181–1194CrossRefGoogle Scholar
  36. Tigges J, Gordon TP, McClure HM, Hall EC, Peters A (1988) Survival rate and life span of rhesus monkeys at the Yerkes regional primate research center. American Journal of Primatology 15:263–273CrossRefGoogle Scholar
  37. Villeda SA et al (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477:90–94CrossRefGoogle Scholar
  38. Von Bernhardi R, Eugenin-von Bernhardi L, Eugenin J (2015) Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci 7 Available at: [Accessed August 19, 2019]
  39. Wake H, Moorhouse AJ, Nabekura J (2011) Functions of microglia in the central nervous system – beyond the immune response. Neuron Glia Biology 7:47–53CrossRefGoogle Scholar
  40. Walberer M, Jantzen SU, Backes H, Rueger MA, Keuters MH, Neumaier B, Hoehn M, Fink GR, Graf R, Schroeter M (2014) In-vivo detection of inflammation and neurodegeneration in the chronic phase after permanent embolic stroke in rats. Brain Research 1581:80–88CrossRefGoogle Scholar
  41. Williams AM, Dennahy IS, Bhatti UF, Halaweish I, Xiong Y, Chang P, Nikolian VC, Chtraklin K, Brown J, Zhang Y, Zhang ZG, Chopp M, Buller B, Alam HB (2019) Mesenchymal stem cell-derived exosomes provide neuroprotection and improve long-term neurologic outcomes in a swine model of traumatic brain injury and hemorrhagic shock. J Neurotrauma 36:54–60CrossRefGoogle Scholar
  42. Wright KT, Masri WE, Osman A, Chowdhury J, Johnson WEB (2011) Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells 29:169–178CrossRefGoogle Scholar
  43. Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, Shang X, Zhang ZG, Chopp M (2012) Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30:1556–1564CrossRefGoogle Scholar
  44. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M (2013) Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33:1711–1715CrossRefGoogle Scholar
  45. Xiong Y, Mahmood A, Chopp M (2017) Emerging potential of exosomes for treatment of traumatic brain injury. Neural Regen Res 12:19–22CrossRefGoogle Scholar
  46. Xiong Y, Mahmood A, Chopp M (2018) Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chinese Journal of Traumatology 21:137–151CrossRefGoogle Scholar
  47. Yang Y, Ye Y, Su X, He J, Bai W, He X (2017) MSCs-derived exosomes and neuroinflammation, neurogenesis and therapy of traumatic brain injury. Front Cell Neurosci 11 Available at: [Accessed June 11, 2018]
  48. Zhang ZG, Chopp M (2016) Exosomes in stroke pathogenesis and therapy. J Clin Invest 126:1190–1197CrossRefGoogle Scholar
  49. Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, & Xiong Ye (2015) Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. Journal of Neurosurgery JNS 122(4):856–867. Retrieved Oct 26, 2019, from
  50. Zhang Y, Chopp M, Zhang ZG, Katakowski M, Xin H, Qu C, Ali M, Mahmood A, Xiong Y (2017) Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochemistry International 111:69–81CrossRefGoogle Scholar
  51. Zhou X, He X, Ren Y (2014) Function of microglia and macrophages in secondary damage after spinal cord injury. Neural Regen Res 9:1787–1795CrossRefGoogle Scholar

Copyright information

© American Aging Association 2019

Authors and Affiliations

  • Veronica Go
    • 1
    Email author
  • Bethany G. E. Bowley
    • 2
  • Monica A. Pessina
    • 2
  • Zheng Gang Zhang
    • 3
  • Michael Chopp
    • 3
    • 4
  • Seth P. Finklestein
    • 6
    • 7
  • Douglas L. Rosene
    • 1
    • 5
  • Maria Medalla
    • 2
  • Benjamin Buller
    • 3
  • Tara L. Moore
    • 2
  1. 1.Deparment of Pharmacology & Experimental TherapeuticsBoston University School of MedicineBostonUSA
  2. 2.Department of Anatomy & NeurobiologyBoston University School of MedicineBostonUSA
  3. 3.Department of NeurologyHenry Ford Health SystemsDetroitUSA
  4. 4.Department of PhysicsOakland UniversityRochesterUSA
  5. 5.Yerkes Primate CenterEmory UniversityAtlantaUSA
  6. 6.Stemetix, Inc.NeedhamUSA
  7. 7.Department of NeurologyMassachusetts General Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations